18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden

2024-9-13

Single-cell, single-nucleus and xenium-based spatial transcriptomics analyses reveal inflammatory activation and altered cell interactions in the hippocampus in mice with temporal lobe epilepsy

2024-9-13

Updates on CAR T cell therapy in multiple myeloma

2024-9-12

Global, regional, and national burden of acute myeloid leukemia, 1990–2021: a systematic analysis for the global burden of disease study 2021

2024-9-11

Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinoma

2024-9-11

Gene therapy for polygenic or complex diseases

2024-9-4

Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy

2024-9-4

Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy

2024-9-4

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment

2024-9-3

The solute carrier transporters (SLCs) family in nutrient metabolism and ferroptosis

2024-9-2

Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications

2024-9-2

mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends

2024-8-31

BRD4: an effective target for organ fibrosis

2024-8-30

A metabolite-based liquid biopsy for detection of ovarian cancer

2024-8-28

Current status and future perspectives of platelet-derived extracellular vesicles in cancer diagnosis and treatment

2024-8-26

Comparison of proton therapy and photon therapy for early-stage non-small cell lung cancer: a meta-analysis

2024-8-26

Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer

2024-8-26

Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021

2024-8-26

CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond

2024-8-23

Targeted protein degradation in hematologic malignancies: clinical progression towards novel therapeutics

2024-8-21

The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy

2024-8-15

The role of macrophage plasticity in neurodegenerative diseases

2024-8-13

Dysregulation of plasma circulating microRNAs in all-cause and cause-specific cancers: the Rotterdam Study

2024-8-13

Trop2-targeted therapy in breast cancer

2024-8-13

Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancer

2024-8-12

Untargeted lipidomics reveals racial differences in lipid species among women

2024-8-9

Transcriptomic changes and gene fusions during the progression from Barrett’s esophagus to esophageal adenocarcinoma

2024-8-7

Cancer immunotherapy and its facilitation by nanomedicine

2024-8-3

Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease

2024-8-2

Redefining prostate cancer risk stratification: a pioneering strategy to estimate outcome based on Ki67 immunoscoring

2024-8-1

Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives

2024-7-30

Blood and urine biomarkers of disease progression in IgA nephropathy

2024-7-29

Advances in targeting cancer-associated fibroblasts through single-cell spatial transcriptomic sequencing

2024-7-29

Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies

2024-7-29

Voltage-gated sodium channels in cancers

2024-7-25

Correction: CRISPR/Cas-based CAR-T cells: production and application

2024-7-23

Effects of protein restriction on insulin-like growth factor (IGF)-1 in men with prostate cancer: results from a randomized clinical trial

2024-7-22

Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma

2024-7-20

The involvement of krüppel-like transcription factor 2 in megakaryocytic differentiation induction by phorbol 12-myrestrat 13-acetate

2024-7-17

Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective

2024-7-17

Correction: Gasdermin E benefits CD8 + T cell mediated anti-immunity through mitochondrial damage to activate cGAS-STING-interferonβ axis in colorectal cancer

2024-7-11

Metabolomic discoveries for early diagnosis and traditional Chinese medicine efficacy in ischemic stroke

2024-6-20

The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma

2024-6-18

Identification of a circulating long non-coding RNA signature panel in plasma as a novel biomarker for the detection of acute/early-stage HIV-1 infection

2024-6-12

Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia

2024-6-10

Gasdermin E benefits CD8+T cell mediated anti-immunity through mitochondrial damage to activate cGAS-STING-interferonβ axis in colorectal cancer

2024-6-9

Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma

2024-6-5

Single-cell and bulk RNA-seq unveils the immune infiltration landscape associated with cuproptosis in cerebral cavernous malformations

2024-6-5

Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancer

2024-6-3

Single-cell and spatial transcriptomics reveal alterations in trophoblasts at invasion sites and disturbed myometrial immune microenvironment in placenta accreta spectrum disorders

2024-6-3